on 9 Aug 2001
Last Applicant/ Owned by
Millennium Pharmaceuticals, Inc.
40 Landsdowne Street
Cambridge,, , 02139
Serial Number
UK00902334647 filed on 9th Aug 2001
Registration Number
UK00902334647 registered on
24th Mar 2003
Correspondent Information
Potter Clarkson LLP
The Belgrave Centre, Talbot Street
Nottingham,
NG1 5GG
Diagnostic assays and test kits for clinical, laboratory, medical and chemical use to diagnose, prognose, predict or treat diseases and for providing genomic and proteomic profiles useful in the selection of therapeutics; assays and test kits for evaluating efficacy of treatments and treatment progress; prognostic test kits for identifying hereditary risk factors; diagnostic preparations, namely, preparations of extracts, assays, nucleic acids, proteins, polypeptides, and antibodies, and molecular arrays of biological materials for clinical or medical laboratory use in Class 1.
Prescription pharmaceutical preparations for use in the diagnosis or treatment of human diseases and disorders, namely, circulatory, respiratory, endocrine, neurologic, cardiovascular, alimentary, oncologic, auto-immune or immune-related, pulmonary, musculoskeletal, lymphatic, gastrointestinal, bone sensory, viral urinary, renal, infectious, metabolic or central nervous system diseases and disorders, excluding analgesics; diagnostic assays and test kits for clinical, laboratory, medical and chemical use to diagnose, prognose, predict or treat diseases and for providing genomic and proteomic profiles useful in the selection of therapeutics; assays and test kits for evaluating efficacy of treatments and treatment progress; prognostic test kits for identifying hereditary risk factors; diagnostic preparations, namely preparations of extracts, assays, nucleic acids, proteins, polypeptides, and antibodies, and molecular arrays of biological materials for clinical or medical laboratory use in Class 5.
Medical and diagnostic services, namely, diagnosing, preventing and predicting disease, identifying hereditary risk factors, diagnostic testing, prognostic testing, gene and protein testing, identifying physiological characteristics, establishing individual preventative programs, establishing disease treatment based on gene and protein expression and/or activity, evaluating clinical trial progress, drug monitoring and computer tracking of a patient's health progress; research services, namely, research, development, validation, testing, data analysis and product development services in the biomedical, genomic pharmacogenomic, diagnostic, clinical trial design, and biotechnology fields; research consulting services, namely, research, development, validation, testing, data analysis, and product development services for others in the biomedical, genomic, pharmaceutical, pharmacogenomics, diagnostic, clinical trial design, and biotechnology fields; computer services, namely, providing access to databases of life sciences information via global, national, and local computer networks in the fields of pharmacogenomics, diagnostics, clinical trial design and biotechnology, computer consulting services, namely, providing access to databases of life sciences information to others via global, national, and local computer networks in the fields of pharmacogenomics, diagnostics, clinical trial design and biotechnology in Class 42.
UK00902334647
Word
Individual